What is the recommended dose of epinephrine (Epi) for adults and children in cases of anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Epinephrine Dosing for Anaphylaxis in Adults and Children

For anaphylaxis, adults and children ≥30 kg should receive 0.3-0.5 mg epinephrine intramuscularly into the anterolateral thigh, while children <30 kg should receive 0.01 mg/kg (maximum 0.3 mg) via the same route. 1

Adult Dosing

  • Adults and children weighing 30 kg (66 lbs) or more should receive 0.3-0.5 mg (0.3-0.5 mL of 1:1000 solution) of epinephrine 1
  • The dose may be repeated every 5-10 minutes as necessary if symptoms persist 1
  • Intramuscular injection into the anterolateral aspect of the thigh (vastus lateralis muscle) is the preferred route for first-aid treatment 2

Pediatric Dosing

  • Children weighing less than 30 kg (66 lbs): 0.01 mg/kg (0.01 mL/kg of 1:1000 solution), up to a maximum of 0.3 mg 1
  • For autoinjector use in children:
    • 0.15 mg autoinjector for children weighing 10-25 kg (22-55 lbs) 2
    • 0.3 mg autoinjector for children weighing approximately 25 kg (55 lbs) or more 2
    • A newer 0.1 mg autoinjector with a shorter needle is better suited for children weighing 7.5-15 kg 3

Route of Administration

  • Intramuscular (IM) injection into the lateral thigh is strongly preferred over subcutaneous administration 2
  • Studies show that IM injection in the lateral thigh leads to peak plasma epinephrine concentrations in 8±2 minutes, compared to 34±14 minutes with subcutaneous injection 2
  • Intravenous administration carries risks of dilution errors and dosing errors and should be reserved for severe anaphylaxis that doesn't respond to IM epinephrine or for hospital settings 2

Repeat Dosing Considerations

  • If symptoms persist, the dose may be repeated every 5-10 minutes as necessary 1
  • Studies indicate that 8-28% of anaphylaxis patients may require a second dose of epinephrine when symptoms fail to resolve after the initial dose 4

Special Considerations

  • For infants weighing less than 10 kg, the standard 0.15 mg autoinjector may exceed the recommended dose, though the clinical significance of this is unclear 3
  • Autoinjector needle length may be too long for many patients weighing less than 15 kg and too short for obese patients weighing more than 30 kg 3
  • In hospital settings, epinephrine drip may be considered for severe cases unresponsive to IM epinephrine, starting at 1-4 mcg/min, titrated up to a maximum of 10 mcg/min 5

Common Pitfalls to Avoid

  • Confusion about proper dosing and route of administration is common among healthcare providers, with only 16.8% of junior doctors in one study administering epinephrine according to guidelines 6
  • Delayed administration of epinephrine contributes to anaphylaxis fatalities; it is most effective when given immediately after symptom onset 7
  • Subcutaneous injection should be avoided due to delayed onset of action 2, 7
  • Intravenous administration should be avoided in first-aid settings due to increased risk of adverse effects 2, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Epinephrine, auto-injectors, and anaphylaxis: Challenges of dose, depth, and device.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2018

Guideline

Epinephrine Drip Dosing for Severe Allergic Reactions/Anaphylaxis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epinephrine (adrenaline) in anaphylaxis.

Chemical immunology and allergy, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.